Target intelligence / Profile preview

TSC22 domain family member 2 (TSC22D2)

Target
TSC22D2
Molecular classification
Transcription factor
01

Overview

TSC22 domain family member 2 (TSC22D2) is a member of the TSC22 domain family of transcription factors, which are characterized by a leucine zipper motif that mediates dimerization and DNA binding[1][2][5]. TSC22D2 reduces levels of nuclear PKM isoform M2, resulting in repression of cyclin CCND1 and reduced cell growth[5]. Its promoter may be regulated by histone H4 transcription factor (HINFP)[3]. The biological and pathological roles of this protein are not as extensively characterized as some other family members, and it is not currently considered a direct therapeutic target[4][5]. Clarifying details: The gene/protein is distinct from the better-studied TSC22 domain family member 1 (TSC22D1). As of current knowledge, TSC22D2 has limited direct therapeutic or disease relevance. There is no evidence it functions as an enzyme, receptor, transporter, or other classical drug target protein family. No small-molecule drugs or clinical interventions are known to target TSC22D2 directly.

Other names
TSC22D2TSC22 domain family protein 2
02

Biological functions

Transcriptional regulationRegulation of cell growth and proliferation
03

Disease associations

Other (not well-established in major disease areas)

Beyond the preview

Go deeper on TSC22 domain family member 2 (TSC22D2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TSC22 domain family member 2 (TSC22D2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call